Evidence map›Paper›PMID 34163064›Full record

ReviewNature protocols2021

Multiplexed bioluminescence-mediated tracking of DNA double-strand break repairs in vitro and in vivo.

Jasper Che-Yung Chien, Christian E Badr, Charles Pin-Kuang Lai

Open access · greenAbstract readReview
In one paragraph

Review in Nature protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jasper Che-Yung ChienInstitute of Atomic and Molecular Sciences, Academia Sinica, Taipei, Taiwan.
Christian E Badr *Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. badr.christian@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-7212-5975
Charles Pin-Kuang Lai *Institute of Atomic and Molecular Sciences, Academia Sinica, Taipei, Taiwan. laicharles@sinica.edu.tw.ORCID http://orcid.org/0000-0001-8050-7060
Institute of Atomic and Molecular Sciences, Academia Sinica · TWHarvard University · US

Funding

Role of ER Stress and Fatty Acid Metabolism in Glioma Stem CellsR01NS113822 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BADR, CHRISTIAN ELIAS · 2020 to 2024
$2.0M
Identifying vulnerabilities and therapeutic targets in Glioma Stem CellsK22CA197053 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI BADR, CHRISTIAN ELIAS · 2015 to 2017
$603k
NCI NIH HHS K22 CA197053NINDS NIH HHS R01 NS113822
6 · The paper itself

Abstract

The dynamics of DNA double-strand break (DSB) repairs including homology-directed repair and nonhomologous end joining play an important role in diseases and therapies. However, investigating DSB repair is typically a low-throughput and cross-sectional process, requiring disruption of cells and organisms for subsequent nuclease-, sequencing- or reporter-based assays. In this protocol, we provide instructions for establishing a bioluminescent repair reporter system using engineered Gaussia and Vargula luciferases for noninvasive tracking of homology-directed repair and nonhomologous end joining, respectively, induced by SceI meganuclease, SpCas9 or SpCas9 D10A nickase-mediated editing. We also describe complementation with orthogonal DSB repair assays and omics analyses to validate the reporter readouts. The bioluminescent repair reporter system provides longitudinal and rapid readout (~seconds per sample) to accurately and efficiently measure the efficacy of genome-editing tools and small-molecule modulators on DSB repair. This protocol takes ~2-4 weeks to establish, and as little as 2 h to complete the assay. The entire bioluminescent repair reporter procedure can be performed by one person with standard molecular biology expertise and equipment. However, orthogonal DNA repair assays would require a specialized facility that performs Sanger sequencing or next-generation sequencing.

Indexed as

DNA Breaks, Double-StrandedAnimalsCell LineCRISPR-Cas SystemsDNA RepairHumansLuminescent MeasurementsMiceMice, TransgenicNeoplasms, Experimental

Identifiers

PMID34163064
PMCPMC9124064
OpenAlexW3176443664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.